Direct-to-consumer prescription drug advertising should be banned

Debate continues over whether direct-to-consumer prescription drug advertising be banned.

Overview Debates Related claims Topics

Insurers should be barred from setting premiums using genetic tests

The FDA drug recall system catches contamination issues before they reach patients

Pharmaceutical manufacturing quality standards are sufficient to prevent particulate contamination

The federal response to the measles outbreak has been sufficient to contain its spread

State-level disaster declarations are an effective tool for controlling measles outbreaks

Parents should not be allowed to select embryos for predicted intelligence

Placebo-controlled trials should be required before approving new medicines

Updated vaccines should undergo full clinical trials before approval

New medicines should have to outperform existing treatments before approval

Governments should license publicly funded drug patents to competitors when prices are unaffordable

Psychedelics should be legal for therapeutic use

Everyone should automatically be an organ donor unless they opt out

Circumcising babies for religious reasons should be illegal

Individual medical freedom should always take precedence over public health

The appeals court should lift the block on Robert F. Kennedy Jr.'s vaccine panel appointments

The Federal Advisory Committee Act's balance requirements are essential safeguards for public health

US regulators should require NAION warnings on GLP-1 drug labels

GLP-1 manufacturers bear liability for not warning US patients about NAION

Pharmaceutical companies have too much influence over healthcare

Everyone should have the right to medically assisted death